Skip to content

Connecting business. Building understanding. Advancing peace.

Daily BriefVerify a certificateDue Diligence
Become a Member

Finance & Investment

Banking, fintech, funds, capital markets and cross-border investment

China–UAE News
Source: PA Media

Dubai Talent Programme Selects 23 Candidates From 14,600 Applications Worldwide

The Dubai Business Associates programme has welcomed 23 professionals from 15 countries for its 12th cohort after receiving 14,600 applications globally. Participants, who include graduates from China's Tsinghua and Peking universities, will complete nine months of business placements and consulting projects across key Dubai public and private sector organisations. The programme is run under Falcon and Associates and has built a network of 350 alumni across 11 previous cohorts.

Industry News
Source: Zawya

Deutsche Bank Expands Dubai Investment Banking Division with Three Key Appointments

Deutsche Bank has announced three senior appointments in its Dubai office to expand its investment banking portfolio and client coverage across the Middle East. The appointments include Ilya Korobov as Director of Debt Capital Markets CEEMEA, Adel Taleb as Director within the Distressed Products Group, and Nitin Sawhney as Head of the Institutional Client Group MENA. The expansion follows major regional sovereign and corporate bond issuances handled by the bank.

Industry News
Source: Arabian Gulf Business Insight | AGBI

Temasek to Open Abu Dhabi and Riyadh Offices, Boosting Regional Deal Competition

Singapore state investor Temasek plans to open offices in Abu Dhabi and Riyadh in the first half of 2027, pending regulatory approvals. The expansion will increase Temasek's global network to 15 offices across 11 countries, serving as strategic hubs for the firm and its portfolio companies. The move introduces heightened competition for regional investments and partnerships alongside Gulf sovereign wealth funds.

Industry News
Source: Big News Network.com

UAE Investments in AI and Genomics Drive Middle East Biopharma Expansion

A report by World Health Expo and Frost & Sullivan indicates that UAE national investments in genomics, artificial intelligence, and advanced manufacturing are transforming Middle Eastern biopharma. The regional precision medicine sector is forecast to expand by over 10 percent over the next five to seven years. Key initiatives include the Emirati Genome Program, Abu Dhabi's AED 42 billion HELM cluster, and the 2025 launch of Mubadala Bio.

The UECN Brief

Policy updates, China–UAE business news and industry insights, delivered to your inbox.

Language
Subscriptions

Double opt-in: we send a confirmation link. Unsubscribe at any time. Privacy